Global Drug Eluting Stents Market

Global Drug Eluting Stents Market Size, Trends, Analysis - Forecasts to 2026 By Drug (Sirolimus, Everolimus, Paclitaxel, Zotarolimus, Biolimus, And Others), By Scaffold (Cobalt-Chromium, Platinum-Chromium, Nitinol, Biodegradable, Others), By Generation (1st generation, 2nd generation, 3rd generation, 4th generation), By End Users (Hospitals, Ambulatory Surgical Centers), By Applications (Coronary Diseases, Peripheral Vascular Diseases), By Region (North America, Europe, Asia Pacific and Rest of the World); End User Landscape and Company, Vendor Landscape, Market Share Analysis & Competitor Analysis

Category Healthcare

Format

This report was recently updated on April 12 2024 with the latest and most recent market numbers

Drug Eluting Stents Market Insights

Drug Eluting Stents Market is estimated to grow at a significant CAGR during the forecast period. A drug eluting stent is a semi-rigid device in the form of a tube that is coated with a drug that helps to prevent restenosis of an arterial blockage when released. The rising geriatric population and the shift from angioplasty to DES for the treatment of atherosclerosis are driving the market growth for drug eluting stents. The growing minimally-invasive technique of DES placing is also propelling the market growth. In addition, sedentary lifestyles, unhealthy food habits, and lack of exercise are fuelling the prevalence rate of atherosclerosis globally which eventually augment the growth of the market. However, price fluctuations and risks associated with DES are likely to hamper the market growth.

Drug Eluting Stents Market: By Drug

On the basis of drug, the market is bifurcated into sirolimus, everolimus, paclitaxel, zotarolimus, biolimus, and others. Sirolimus segment is projected to grow at the highest growth rate during the forecast period. The availability of less ate lumen loss and less angiographic restenosis are driving the market growth. Sirolimus is a macrolide compound that is used to coat coronary stents, and used to treat a rare lung disease called lymphangioleiomyomatosis. This drug is also used to prevent organ transplant rejection.

Drug Eluting Stents Market: By Scaffold

On the basis of scaffold, the market is bifurcated into cobalt-chromium, platinum-chromium, nitinol, and biodegradable, among others. The cobalt-chromium is estimated to hold the largest share of the market during the forecast period.

Drug Eluting Stents Market: By End User

On the basis of end users, the market is bifurcated into hospitals and ambulatory surgical centers. Ambulatory surgical centers segment is expected to grow at a rapid pace during the forecast period due to a shift of coronary interventions from hospitals to ambulatory surgical centers. The rising prevalence of chronic diseases, such as diabetes and cardiac arrest, is anticipated to further boost the demand for drug eluting stents during the forecast period.

Drug Eluting Stents Market: By Application

On the basis of application, the market is bifurcated into coronary diseases and peripheral vascular diseases. The peripheral vascular segment is projected to dominate the market during the forecast period. The widespread demand among the customers for drug-eluting vascular stents for the treatment of peripheral vascular diseases is propelling the market growth.

Drug Eluting Stents Market: By Region

North America is anticipated to dominate the market during the forecast period owing to the emergence of stringent regulatory guidelines for medical device manufacturing and approval. Europe is expected to grow at the highest pace during the forecast period owing to the rise in the number of third-generation DES with the CE mark and the rising popularity of polymer technology for the production of stents. Growing patient awareness related to the commercial availability of the products, government funding, constantly improving healthcare infrastructure drives the market growth in the region.

Drug Eluting Stents Market: End Use Landscape

The end user landscape chapter entails a list of current and prospective consumer prevailing in the market. This section briefs about the company’s address, contact details, products and regional presence of the company who are prone to purchase the products. The key end users are Lepu Medical Technology, Terumo Medical Corporation, Cook Medical etc.

Drug Eluting Stents Market: Vendor Landscape

The reports contain a chapter dedicated to the vendors operating in the drug eluting stents market, covering raw material, equipment developer, distributors and manufacturers. The report provides these insights on a regional as well as country level. This section incorporates contact details, experience, and products manufactured/supplied and geographical presence of the companies.

Drug Eluting Stents Market Share & Competitor Analysis

Some of the key players operating in the market space include: Biotronik, Boston Scientific Corporation, Medtronic, Abbott, Biosensors International Group, Ltd (Bluesail Medical Co., Ltd.), MicroPort Scientific Corporation, Terumo Corporation, Cook, STENTYS SA, and Medinol Ltd among others.

Please note: This is not an exhaustive list of companies profiled in the report.

Check the Press Release on Global Drug Eluting Stents Market Report

Drug Eluting Stents Market: By Drug

Introduction
1. Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
Sirolimus
1. Sirolimus: Drug Eluting Stents Market, 2018-2026 (USD Million)
Everolimus
1. Everolimus: Drug Eluting Stents Market, 2018-2026 (USD Million)
Paclitaxel
1. Paclitaxel: Drug Eluting Stents Market, 2018-2026 (USD Million)
Zotarolimus
1. Zotarolimus: Drug Eluting Stents Market, 2018-2026 (USD Million)
Biolimus
1. Biolimus: Drug Eluting Stents Market, 2018-2026 (USD Million)
Others
1. Others: Drug Eluting Stents Market, 2018-2026 (USD Million)

Drug Eluting Stents Market: By Scaffold

Introduction
1. Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
Cobalt-Chromium
1. Cobalt-Chromium: Drug Eluting Stents Market, 2018-2026 (USD Million)
Platinum-Chromium
1. Platinum-Chromium: Drug Eluting Stents Market, 2018-2026 (USD Million)
Nitinol
1. Nitinol: Drug Eluting Stents Market, 2018-2026 (USD Million)
Biodegradable
1. Biodegradable: Drug Eluting Stents Market, 2018-2026 (USD Million)
Others
1. Others: Drug Eluting Stents Market, 2018-2026 (USD Million)

Drug Eluting Stents Market: By Generation

Introduction
1. Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
1st generation
1. 1st generation: Drug Eluting Stents Market, 2018-2026 (USD Million)
2nd generation
1. 2nd generation: Drug Eluting Stents Market, 2018-2026 (USD Million)
3rd generation
1. 3rd generation: Drug Eluting Stents Market, 2018-2026 (USD Million)
4th generation
1. 4th generation: Drug Eluting Stents Market, 2018-2026 (USD Million)

Drug Eluting Stents Market: By End User

Introduction
1. Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
Hospitals
1. Hospitals: Drug Eluting Stents Market, 2018-2026 (USD Million)
Ambulatory Surgical Centers
1. Ambulatory Surgical Centers: Drug Eluting Stents Market, 2018-2026 (USD Million)

Drug Eluting Stents Market: By Application

Introduction
1. Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
Coronary Diseases
1. Coronary Diseases: Drug Eluting Stents Market, 2018-2026 (USD Million)
Peripheral Vascular Diseases
1. Peripheral Vascular Diseases: Drug Eluting Stents Market, 2018-2026 (USD Million)

Drug Eluting Stents Market: By Region

Introduction
1. Global Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
North America
1. North America Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Drug
    1. North America Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
  2. By Scaffold
    1. North America Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
  3. By Generation
    1. North America Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
  4. By End Users
    1. North America Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
  5. By Application
    1. North America Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
  6. By Country
    1. U.S
      1. By Drug
        
        U.S Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        U.S Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        U.S Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        U.S Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        U.S Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    2. Canada.
      1. By Drug
        
        Canada Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Canada Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Canada Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Canada Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Canada Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    3. Mexico
      1. By Drug
        
        Mexico Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Mexico Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Mexico Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Mexico Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Mexico Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
Europe
1. Europe Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Drug
    1. Europe Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
  2. By Scaffold
    1. Europe Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
  3. By Generation
    1. Europe Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
  4. By End Users
    1. Europe Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
  5. By Application
    1. Europe Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
  6. By Country
    1. Germany
      1. By Drug
        
        Germany Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Germany Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Germany Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Germany Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Germany Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    2. UK
      1. By Drug
        
        UK Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        UK Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        UK Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        UK Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        UK Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    3. France
      1. By Drug
        
        France Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        France Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        France Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        France Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        France Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    4. Italy
      1. By Drug
        
        Italy Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Italy Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Italy Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Italy Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Italy Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    5. Spain
      1. By Drug
        
        Spain Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Spain Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Spain Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Spain Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Spain Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    6. Rest Of Europe
      1. By Drug
        
        Rest Of Europe Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Rest Of Europe Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Rest Of Europe Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Rest Of Europe Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Rest Of Europe Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
Asia Pacific
1. Asia Pacific Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Drug
    1. Asia Pacific Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
  2. By Scaffold
    1. Asia Pacific Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
  3. By Generation
    1. Asia Pacific Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
  4. By End Users
    1. Asia Pacific Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
  5. By Country
    1. China
      1. By Drug
        
        China Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        China Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        China Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        China Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        China Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    2. Japan
      1. By Drug
        
        Japan Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Japan Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Japan Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Japan Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Japan Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    3. India
      1. By Drug
        
        India Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        India Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        India Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        India Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        India Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    4. South Korea
      1. By Drug
        
        South Korea Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        South Korea Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        South Korea Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        South Korea Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        South Korea Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
Central & South America
1. Central & South America Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Drug
    1. Central & South America Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
  2. By Scaffold
    1. Central & South America Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
  3. By Generation
    1. Central & South America Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
  4. By End Users
    1. Central & South America Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
  5. By Application
    1. Central & South America Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
  6. By Country
    1. Brazil
      1. By Drug
        
        Brazil Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Brazil Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Brazil Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Brazil Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Brazil Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
Middle East & Africa
1. Middle East & Africa Drug Eluting Stents Market, Regional Analysis, 2018-2026 (USD Million)
  1. By Drug
    1. Middle East & Africa Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
  2. By Scaffold
    1. Middle East & Africa Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
  3. By Generation
    1. Middle East & Africa Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
  4. By End Users
    1. Middle East & Africa Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
  5. By Application
    1. Middle East & Africa Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
  6. By Country
    1. Saudi Arabia
      1. By Drug
        
        Saudi Arabia Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        Saudi Arabia Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        Saudi Arabia Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        Saudi Arabia Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        Saudi Arabia Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)
    2. UAE
      1. By Drug
        
        UAE Drug Eluting Stents Market, By Drug, 2018-2026 (USD Million)
      2. By Scaffold
        
        UAE Drug Eluting Stents Market, By Scaffold, 2018-2026 (USD Million)
      3. By Generation
        
        UAE Drug Eluting Stents Market, By Generation, 2018-2026 (USD Million)
      4. By End Users
        
        UAE Drug Eluting Stents Market, By End Users, 2018-2026 (USD Million)
      5. By Application
        
        UAE Drug Eluting Stents Market, By Application, 2018-2026 (USD Million)

The global Drug Eluting Stents Market has been studied from the year 2017 till 2026. However, the CAGR provided in the report is from the year 2018 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply side analysis for the Drug Eluting Stents Market.

Drug Eluting Stents Market

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Drug Eluting Stents Market

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the companies and customer analytics.

Drug Eluting Stents Market